Help us improve the FORRT website

Plasma

 

A Public Option for Clinical Trials? Lessons from Convalescent Plasma

The case of clinical trials for convalescent plasma during COVID-19 illustrates important lessons for realizing public sector approaches to biomedical research and development. These lessons, centering on mission, transparency, and spillover effects, …

Help us improve the FORRT website

We would be grateful if you could complete this survey. Your feedback will directly inform improvements to navigation, accessibility, and content structure.
Note:All answers are anonymous and will help us make the website better for everyone!

Take the Survey